Presentation is loading. Please wait.

Presentation is loading. Please wait.

Slide 1 of 42 IAS–USA AU EDITED FINAL: 03-18-13 Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director,

Published byJohnathan Glenn Modified over 8 years ago

Similar presentations

Presentation on theme: "Slide 1 of 42 IAS–USA AU EDITED FINAL: 03-18-13 Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director,"— Presentation transcript:

1 Slide 1 of 42 IAS–USA AU EDITED FINAL: 03-18-13 Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director, BC-Centre for Excellence in HIV/AIDS at Providence Health Care Past President, International AIDS Society (2008-2010) Treatment as Prevention: The Key to an AIDS-Free Generation

2 Slide 2 of 44 January 2004 Summer of 1996 Year Summer of 2000 Phase I Phase II Phase III Montaner et al, Lancet, 2010 Increasing HAART Coverage within Evolving Guidelines in BC N = 7492 by the end of 2011

3 Slide 3 of 44 Pre-HAART CD4 counts in BC by year, 2003-2012 Lima et al, in preparation, 2013

4 Slide 4 of 44 Adherence to HAART in BC by year, 1996-2012 Lima et al, in preparation, 2013

5 Slide 5 of 44

6 Slide 6 of 44 HIV Drug Resistance in BC by year, 1996-2012 Lima et al, in preparation, 2013

7 Slide 7 of 44 BC: All Cause Mortality (#) Montaner et al, TasP Workshop, April 2012

8 Slide 8 of 44 AIDS New Cases for BC by year, 1996- 2011 Lima et al, in preparation, 2013

9 Slide 9 of 44 BC: HIV Prevalence and TB Incidence James Johnston, WIP, May 2013

10 Slide 10 of 44 HAART Use & New HIV Diagnoses for BC by year, 1996-2012 Lima et al, in preparation, 2013 HIV Incidence Active on HAART New HIV Diagnoses (All) New HIV Diagnoses (Ever IDU)

11 Slide 11 of 44 Annual rates (per 100,000 population) for new cases of genital chlamydia, genital gonorrhea, infectious syphilis and hepatitis C, 1996-2012 Lima et al, in preparation, 2013 Hepatitis C Syphilis GonorrheaChlamydia

12 Slide 12 of 44 Programmatic Compliance Score Assesses the impact of non- compliance with HIV treatment guidelines on all-cause mortality PCS components include: Baseline CD4 > 200/mm3 Three CD4 in 1 st year Three VL in 1 st year Baseline resistance Recommended HAART Undetectable pVL at 9 months Failure to meet a given component add one to the score PCS predicts mortality Lima et al. PLoS ONE 7(11): e47859. 2012

13 Slide 13 of 44 PCS in BC 2000 to 2011 Lima et al, in preparation, 2013

14 Slide 14 of 44 R Lester, M Morshed, and M Gilbert, BCMJ, May 4 th 2013

15 Slide 15 of 44 red = drug resistance at baseline node size = date of baseline sample

16 Slide 16 of 44 HIV Diagnoses by Region and Year Public Health Agency of Canada

17 Slide 17 of 44 TasP Monitoring in the Real World In a perfect world, all HIV infected individuals would follow the same pathway in the spectrum of engagement into care: In the real world, there is attrition between each of these steps and individuals are often lost-to-follow-up. Understanding the attrition points (leakage), and their causes are essential to optimize the effectiveness of TasP. This can only be achieved by comprehensively monitoring standardized metrics, on a longitudinal basis and accounting for multiple sources of bias and heterogeneity (i.e.: geographic, socio-demographic, risk factors, etc).

18 Link 4th Intl HIV TREATMANT AS PREVENTION Workshop April 1 st to 4 th 2014 - Vancouver, BC, Canada.

19 Slide 19 of 44 In Collaboration with PHC, VCHA, NHA, PHSA, Community, and MoH

Download ppt "Slide 1 of 42 IAS–USA AU EDITED FINAL: 03-18-13 Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director,"

Similar presentations

HIV-infection in Russia Alexander Panteleev Head of the HIV/TB department City TB Hospital # 2, St-Petersburg, Russia.

HIV-infection in Russia Alexander Panteleev Head of the HIV/TB department City TB Hospital # 2, St-Petersburg, Russia.
Delphine Sculier, MD,MPH Stop TB Department World Health Organisation Geneva, Switzerland Update on the revision of ART guidelines for TB patients.

Delphine Sculier, MD,MPH Stop TB Department World Health Organisation Geneva, Switzerland Update on the revision of ART guidelines for TB patients.
Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director, BC-Centre for Excellence in HIV/AIDS at Providence.

Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director, BC-Centre for Excellence in HIV/AIDS at Providence.
Page 1 Peer-delivered HIV testing and counseling among people who inject drugs in Bangkok, Thailand Lianping Ti 1 Kanna Hayashi 1,2 Karyn Kaplan 3 Paisan.

Page 1 Peer-delivered HIV testing and counseling among people who inject drugs in Bangkok, Thailand Lianping Ti 1 Kanna Hayashi 1,2 Karyn Kaplan 3 Paisan.
Slide 1 of 42 IAS–USA Treatment as Prevention: Evaluating the Impact of HAART Expansion The British Columbia (BC) Experience AU EDITED FINAL: 03-18-13.

Slide 1 of 42 IAS–USA Treatment as Prevention: Evaluating the Impact of HAART Expansion The British Columbia (BC) Experience AU EDITED FINAL:
Cristin Muecke, RMOH Nick Scott, ED AIDS NB.  Why HIV testing remains important  Treatment as prevention  Discuss advantages/disadvantages of various.

Cristin Muecke, RMOH Nick Scott, ED AIDS NB.  Why HIV testing remains important  Treatment as prevention  Discuss advantages/disadvantages of various.
The HIV Engagement in Care Cascade Edward Gardner, MD Associate Professor of Medicine Denver Public Health University of Colorado Denver.

The HIV Engagement in Care Cascade Edward Gardner, MD Associate Professor of Medicine Denver Public Health University of Colorado Denver.
Role of Routine HIV Testing in Concentrated Epidemics Operations Research for Optimizing the HIV Testing Program in an Urban Canadian Setting K Vasarhelyi,

Role of Routine HIV Testing in Concentrated Epidemics Operations Research for Optimizing the HIV Testing Program in an Urban Canadian Setting K Vasarhelyi,
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,

Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,

HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Treatment as prevention (TASP) for HIV and HCV: The evidence and modelling Peter Vickerman.

Treatment as prevention (TASP) for HIV and HCV: The evidence and modelling Peter Vickerman.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.

Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Dr. Yogan Pillay Deputy Director General National Department of Health, South Africa Monday 1 July 2013 OPERATIONAL AND PROGRAMMATIC CONSIDERATIONS IN.

Dr. Yogan Pillay Deputy Director General National Department of Health, South Africa Monday 1 July 2013 OPERATIONAL AND PROGRAMMATIC CONSIDERATIONS IN.
Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.

Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.
1 HIV/STD Trends in Texas Sharon K. Melville, M.D., M.P.H. Texas Department of State Health Services Texas Public Health Association April 22, 2010.

1 HIV/STD Trends in Texas Sharon K. Melville, M.D., M.P.H. Texas Department of State Health Services Texas Public Health Association April 22, 2010.
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.

Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
Community viral load and newly reported HIV infections in Switzerland Matthias Egger Professor of Epidemiology & Public Health Institute of Social and.

Community viral load and newly reported HIV infections in Switzerland Matthias Egger Professor of Epidemiology & Public Health Institute of Social and.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.

Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
HIV in Suriname Ministry of Health Suriname M.Sigrid Mac Donald – Ottevanger, MD Focal point HIV Treatment and Care, NAP.

HIV in Suriname Ministry of Health Suriname M.Sigrid Mac Donald – Ottevanger, MD Focal point HIV Treatment and Care, NAP.
STOP HIV/AIDS Rolando Barrios, MD, FRCPC Assistant Director BC Centre for Excellence in HIV/AIDS Assistant Medical Director HIV/AIDS Program Providence.

STOP HIV/AIDS Rolando Barrios, MD, FRCPC Assistant Director BC Centre for Excellence in HIV/AIDS Assistant Medical Director HIV/AIDS Program Providence.

Similar presentations

Ads by Google